Cellarity
Mauricio Cortes is a highly experienced professional in the field of biology, currently serving as Senior Director and Head of Platform Biology at Cellarity since January 2019, with a notable progression from Associate Director to Director in the organization. Prior to Cellarity, Mauricio worked at CRISPR Therapeutics from November 2016 to January 2019 as a Scientist II, focusing on cellular assay development and contributing to the first CRISPR-Cas9 gene-based clinical trial for Beta-thalassemia and sickle cell disease. Additional experience includes a research fellowship at Harvard Medical School, where Mauricio studied vitamin D’s impact on hematopoietic stem cell homeostasis, and a postdoctoral fellowship at The University of Chicago, which involved investigating glycosaminoglycans in embryonic stem cells. Mauricio earned a PhD in Biochemistry & Molecular Biology from the University of Chicago and a B.A. in Chemistry from Kenyon College.
This person is not in any teams
This person is not in any offices
Cellarity
1 followers
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.